LabCorp announced its Q1 2020 results with a revenue of $2.82 billion, a 1% increase compared to last year. Diluted EPS was ($3.27), including goodwill and other asset impairments. Adjusted EPS was $2.37, negatively impacted by COVID-19. Free cash flow was $97 million, up 36% year-over-year. The company withdrew its 2020 guidance due to the unpredictability of the COVID-19 pandemic.
Q1 revenue increased by 1% year-over-year to $2.82 billion.
Diluted EPS was ($3.27), which include goodwill and other asset impairments of $4.43 per share.
Adjusted EPS was $2.37, negatively impacted by an estimated $0.55 per share from the COVID-19 pandemic.
Free cash flow was $97 million, a 36% increase compared to the previous year.
Given the ongoing and rapidly changing nature of the COVID-19 pandemic, there is significant uncertainty regarding the duration and severity of the pandemic as well as any future government restrictions. As a result, the Company is withdrawing its 2020 financial guidance provided on February 13, 2020.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance